Long
TRACON Pharmaceuticals Announces FDA Approval of Amended ENVASAR
TCON: TRACON Pharmaceuticals, Inc.
2022-03-10 08:05:00
TRACON Pharmaceuticals Announces FDA Approval of Amended ENVASARC Protocol
2022-03-10 08:05:00
TRACON Pharmaceuticals Announces FDA Approval of Amended ENVASARC Protocol
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.